| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $181K | — |
| Cost of Revenue | $172K | — |
| Gross Profit | $9K | — |
| R&D Expense | $4.5M | -0.2% |
| SG&A Expense | $5.1M | +15.0% |
| Operating Income | -$9.6M | -7.8% |
| Pre-tax Income | -$9.5M | -7.5% |
| Income Tax | $14K | -51.7% |
| Net Income | -$9.5M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $8.7M | -21.4% |
| Accounts Receivable | $126K | — |
| Current Assets | $9.0M | -20.3% |
| Total Assets | $9.4M | -20.2% |
| Current Liabilities | $1.2M | +7.8% |
| Total Liabilities | $1.3M | -5.0% |
| Stockholders' Equity | $8.1M | -22.2% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$6.8M | +6.7% |
| Capital Expenditures | $3K | -82.4% |
| Investing Cash Flow | -$3K | +82.4% |
| Financing Cash Flow | $4.5M | -25.8% |
| Free Cash Flow | -$6.8M | +6.9% |
| EPS (Basic) | $0.25 | -19.4% |
| EPS (Diluted) | $0.25 | -19.4% |